IP Library Granted Patent US 12,240,772
Granted Patent B2
US 12,240,772 · App. 18/628,119 · Granted Mar 4, 2025

Treatment of aqueous composition with metal component

Inventors: Carlos Borras (Ruskin, FL); Donald A. Luke (Valrico, FL)
Assignee: NuQuatic, LLC
C02F1/463C02F1/46176C02F2101/105C02F2101/36C02F2303/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,240,772
App. No.
18/628,119
Granted
Mar 4, 2025
Kind
B2
Abstract

A method of treating feed water includes adding a metal component to the feed water to form a clarified aqueous composition.

Claims (31)

1. A method of treating feed water, the method comprising:

adding a metal component comprising a metal that is aluminum to the feed water, wherein the feed water comprises a fluoroalkyl compound that is a perfluoroalkyl or polyfluoroalkyl substance (PFAS), perfluoroalkyl substance, a polyfluoroalkyl substance, a perfluoroalkyl acid (PFAA), or a combination thereof, wherein the metal component comprises an ion of the metal, a solid or dissolved compound of the metal, an elemental form of the metal, or a combination thereof, wherein the addition of the metal component to the feed water forms a solid;

removing the solid from the metal component-treated feed water, to form a clarified aqueous composition and to form an aqueous concentrate having a higher concentration of the solid than the clarified aqueous composition, wherein the aqueous concentrate comprises the metal component added to the feed water, and wherein the clarified aqueous composition has a lower concentration of the fluoroalkyl compound as compared to the feed water; and

reusing at least some of the metal component in the aqueous concentrate as 1 wt % to 100 wt % of the metal component that is added to the feed water.

2. The method of claim 1 , wherein the metal component comprises an Al ion and/or aluminum hydroxide.

3. The method of claim 1 , wherein adding the metal component to the feed water comprises adding to the feed water a salt of the metal of the metal component.

4. The method of claim 1 , wherein the metal of the metal component is produced by a galvanic or electrolytic cell, wherein the addition of the metal component to the feed water occurs externally to the galvanic or electrolytic cell.

5. The method of claim 1 , further comprising acidifying the aqueous concentrate to bring a pH of the aqueous concentrate to a pH of 0.5 to 5 sufficient to at least partially dissolve one or more salts comprising the metal of the metal component added to the feed water, and reusing at least some of the metal of the metal component in the acidified aqueous concentrate as 1 wt % to 100 wt % of the metal component that is added to the feed water.

6. The method of claim 5 , further comprising purging one or more acidification contaminants from the acidified aqueous concentrate.

7. The method of claim 5 , wherein the contacting of the feed water and the metal component forms a metal component-treated fluoroalkyl compound, further comprising performing a secondary separation to separate a residual solution from the aqueous concentrate after the acidifying to concentrate the metal component-treated fluoroalkyl compound in the aqueous concentrate and to form the residual solution separated therefrom.

8. The method of claim 7 , wherein a ratio of a volume of the aqueous concentrate having the residual solution removed therefrom to a volume of the acidified aqueous concentrate prior to removal of the residual solution therefrom is 1:100,000 to 1:1.

9. The method of claim 5 , wherein the acidified aqueous concentrate comprises a metal component-treated fluoroalkyl compound formed by addition of the metal component to the feed water, wherein the method further comprises destroying the fluoroalkyl compound in the acidified aqueous concentrate, wherein destroying the fluoroalkyl compound comprises thermal treatment, treatment with an electrolytic cell, plasma reactor, supercritical water, combustion, chemical treatment, or a combination thereof.

10. The method of claim 1 , wherein the method is free of treating the feed water or clarified aqueous composition with a galvanic cell.

11. The method of claim 1 , further comprising treating the clarified aqueous composition with a galvanic cell, to form product water.

12. The method of claim 11 , wherein the galvanic cell comprises:

an anode comprising Al; and

a cathode having a different composition than the anode, wherein the cathode comprises Cu.

13. The method of claim 1 , further comprising purging one or more acidification contaminants from a recycle stream comprising the metal component from the aqueous concentrate prior to or during combining the recycle stream and the feed water.

14. A method of treating feed water, the method comprising:

performing a treatment comprising adding a metal component comprising aluminum to feed water comprising a fluoroalkyl compound to form a solid comprising a metal component-treated fluoroalkyl compound, wherein the metal component is an ion of the aluminum, a solid or dissolved compound of the aluminum, an elemental form of the aluminum, or a combination thereof;

removing the solid from the feed water to form a clarified aqueous composition having a lower concentration of the fluoroalkyl compound than the feed water and to form an aqueous concentrate having a higher concentration of the solid than the clarified aqueous composition;

acidifying the aqueous concentrate;

performing a secondary separation to separate a residual solution from the aqueous concentrate after the acidification and to concentrate the metal component-treated fluoroalkyl compound in the aqueous concentrate; and

adding the metal component from the residual solution to the feed water prior to or during the treatment.

15. A method of treating feed water, the method comprising:

performing a treatment comprising adding a metal component comprising aluminum to feed water comprising a fluoroalkyl compound to form a solid comprising a metal component-treated fluoroalkyl compound, wherein the metal component comprises an ion of the aluminum, a solid or dissolved compound of the aluminum, an elemental form of the aluminum, or a combination thereof;

removing the solid from the feed water to form a clarified aqueous composition having a lower concentration of the fluoroalkyl compound than the feed water and to form an aqueous concentrate having a higher concentration of the solid than the clarified aqueous composition;

acidifying the aqueous concentrate;

performing a secondary separation to separate a residual solution from the aqueous concentrate after the acidification and to concentrate the metal component-treated fluoroalkyl compound in the aqueous concentrate;

purging one or more acidification contaminants from the residual solution; and

adding the metal component from the residual solution to the feed water prior to or during the treatment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: BORRAS, CARLOS; LUKE, DAVID A.
To: NUQUATIC, LLC
Reel/Frame 067196/0819 →
Continuity (5)
Provisional Application 63604373 · Nov 30, 2023
Provisional Application 63457215 · Apr 5, 2023
Provisional Application 63470046 · May 31, 2023
Provisional Application 63544328 · Oct 16, 2023
Related Publication 20240336501A1 · Oct 10, 2024
References Cited (356)
US 1018355A · Galbreath · 1912 [cited by applicant]
US 2449706A · Jones · 1948 [cited by applicant]
US 3385785A · Forrest et al. · 1968 [cited by applicant]
US 3425925A · Fleischman · 1969 [cited by applicant]
US 3660162A · Eisenberg · 1972 [cited by applicant]
US 3766045A · Itakura et al. · 1973 [cited by applicant]
US 3846300A · Inoue · 1974 [cited by applicant]
US 3901804A · Ohuchi et al. · 1975 [cited by applicant]
US 4011151A · Ito et al. · 1977 [cited by applicant]
US 4179347A · Krause et al. · 1979 [cited by applicant]
US 4388195A · Von Hagel et al. · 1983 [cited by applicant]
US 4655895A · Feofanov et al. · 1987 [cited by applicant]
US 5167777A · Kaczur et al. · 1992 [cited by applicant]
US 5348629A · Khudenko · 1994 [cited by applicant]
US 5439566A · Zucker · 1995 [cited by applicant]
US 5454917A · Mattison et al. · 1995 [cited by applicant]
US 5876575A · Kump · 1999 [cited by applicant]
US 5976383A · Guess et al. · 1999 [cited by applicant]
US 6149797A · Carey et al. · 2000 [cited by applicant]
US 6180014B1 · Salama · 2001 [cited by applicant]
US 6210587B1 · Vion · 2001 [cited by applicant]
US 6893567B1 · Vanotti et al. · 2005 [cited by applicant]
US 7118665B2 · Kin et al. · 2006 [cited by applicant]
US 7582198B2 · Wilkins et al. · 2009 [cited by applicant]
US 7704353B2 · Stadelmann et al. · 2010 [cited by applicant]
US 7815779B2 · Flettner · 2010 [cited by applicant]
US 7858598B2 · Yang et al. · 2010 [cited by applicant]
US 8147695B2 · Banerjee et al. · 2012 [cited by applicant]
US 8673129B2 · Gordon et al. · 2014 [cited by applicant]
US 8715469B2 · Pancurák et al. · 2014 [cited by applicant]
US 8926804B2 · Pancurák et al. · 2015 [cited by applicant]
US 9067801B2 · Nagghappan · 2015 [cited by applicant]
US 9067807B2 · Soane et al. · 2015 [cited by applicant]
US 9346692B2 · Combs et al. · 2016 [cited by applicant]
US 9446974B2 · Milner et al. · 2016 [cited by applicant]
US 9580338B2 · Fujikane et al. · 2017 [cited by applicant]
US 9593030B2 · Fujikane et al. · 2017 [cited by applicant]
US 9617175B2 · Monzyk et al. · 2017 [cited by applicant]
US 9637403B2 · Mckay et al. · 2017 [cited by applicant]
US 9865860B2 · Fauland · 2018 [cited by applicant]
US 10003095B2 · Kovacs et al. · 2018 [cited by applicant]
US 10071921B2 · Johnson et al. · 2018 [cited by applicant]
US 10173914B2 · Chidambaran et al. · 2019 [cited by applicant]
US 10230119B2 · Kovacs et al. · 2019 [cited by applicant]
US 10266428B1 · Brian · 2019 [cited by applicant]
US 10343937B2 · Casbeer et al. · 2019 [cited by applicant]
US 10427195B2 · Ball · 2019 [cited by applicant]
US 10513786B2 · Beddoes et al. · 2019 [cited by applicant]
US 10519052B2 · Ball et al. · 2019 [cited by applicant]
US 10538436B2 · Hu et al. · 2020 [cited by applicant]
US 10611651B2 · Martikainen et al. · 2020 [cited by applicant]
US 10665846B2 · Fauland · 2020 [cited by applicant]
US 10676378B2 · Tandukar et al. · 2020 [cited by applicant]
US 10700392B2 · Pantel et al. · 2020 [cited by applicant]
US 10752521B2 · Nelson · 2020 [cited by applicant]
US 10800678B2 · Gifford et al. · 2020 [cited by applicant]
US 10808327B2 · Griffis et al. · 2020 [cited by applicant]
US 10865128B2 · Ball · 2020 [cited by applicant]
US 10882766B2 · Taylor · 2021 [cited by applicant]
US 10954144B2 · Ball et al. · 2021 [cited by applicant]
US 11136248B2 · Pettersson et al. · 2021 [cited by applicant]
US 11148964B2 · Ball · 2021 [cited by applicant]
US 11220443B2 · Borras et al. · 2022 [cited by applicant]
US 11225420B2 · Borras et al. · 2022 [cited by applicant]
US 11312646B2 · Gunasekaran et al. · 2022 [cited by applicant]
US 11345620B2 · Zhu et al. · 2022 [cited by applicant]
US 11384441B2 · Beddoes et al. · 2022 [cited by applicant]
US 11401180B2 · Dejarme et al. · 2022 [cited by applicant]
US 11401181B1 · Borras et al. · 2022 [cited by applicant]
US 11407666B2 · Rosansky et al. · 2022 [cited by applicant]
US 11433152B2 · Saue · 2022 [cited by applicant]
US 11512011B2 · Huang et al. · 2022 [cited by applicant]
US 11512012B2 · Chiang et al. · 2022 [cited by applicant]
US 11541438B2 · Morrell · 2023 [cited by applicant]
US 11548800B2 · Franceschi-Hofmann et al. · 2023 [cited by applicant]
US 11584665B2 · Green et al. · 2023 [cited by applicant]
US 11623884B1 · Menon et al. · 2023 [cited by applicant]
US 11643339B2 · Nelson · 2023 [cited by applicant]
US 11679999B2 · Newell et al. · 2023 [cited by applicant]
US 11713261B2 · Griffis et al. · 2023 [cited by applicant]
US 11780746B2 · Duckworth et al. · 2023 [cited by applicant]
US 11780753B2 · Dejarme et al. · 2023 [cited by applicant]
US 11896948B2 · Chang et al. · 2024 [cited by applicant]
US 12122691B1 · Borras et al. · 2024 [cited by applicant]
US 12168621B2 · Borras et al. · 2024 [cited by applicant]
US 20010000485A1 · Ying et al. · 2001 [cited by applicant]
US 20030168411A1 · Hiro et al. · 2003 [cited by applicant]
US 20030226803A1 · Kamiya et al. · 2003 [cited by applicant]
US 20040151957A1 · Brooks et al. · 2004 [cited by applicant]
US 20040251212A1 · Ikematsu et al. · 2004 [cited by applicant]
US 20050011765A1 · Omasa · 2005 [cited by applicant]
US 20050173262A1 · Nakanishi et al. · 2005 [cited by applicant]
US 20060000784A1 · Khudenko · 2006 [cited by applicant]
US 20060096853A1 · King · 2006 [cited by applicant]
US 20060254929A1 · Mikio · 2006 [cited by applicant]
US 20090120863A1 · Salama et al. · 2009 [cited by applicant]
US 20090282627A1 · Porat · 2009 [cited by applicant]
US 20100000924A1 · Hayashi et al. · 2010 [cited by applicant]
US 20100051477A1 · Jeon et al. · 2010 [cited by applicant]
US 20100126879A1 · Wilman et al. · 2010 [cited by applicant]
US 20110223523A1 · Lopez et al. · 2011 [cited by applicant]
US 20120037498A1 · Pancurak et al. · 2012 [cited by applicant]
US 20130162097A1 · Shinmoto et al. · 2013 [cited by applicant]
US 20130180857A1 · Heffernan et al. · 2013 [cited by applicant]
US 20130220919A1 · Bilbao et al. · 2013 [cited by applicant]
US 20130277231A1 · Greenberg · 2013 [cited by applicant]
US 20130284678A1 · Daly et al. · 2013 [cited by applicant]
US 20140327239A1 · Stanley · 2014 [cited by applicant]
US 20150001094A1 · Ibeid et al. · 2015 [cited by applicant]
US 20150151985A1 · Johnson et al. · 2015 [cited by applicant]
US 20180141836A1 · Hu et al. · 2018 [cited by applicant]
US 20190002321A1 · Grönfors et al. · 2019 [cited by applicant]
US 20190092653A1 · Arbeus et al. · 2019 [cited by applicant]
US 20190185351A1 · Huang et al. · 2019 [cited by applicant]
US 20200010341A1 · Harvey et al. · 2020 [cited by applicant]
US 20200029714A1 · Nguyen et al. · 2020 [cited by applicant]
US 20200165149A1 · Zhu et al. · 2020 [cited by applicant]
US 20200270149A1 · Bejan et al. · 2020 [cited by applicant]
US 20200325041A1 · Cosentino et al. · 2020 [cited by applicant]
US 20200369547A1 · Davy et al. · 2020 [cited by applicant]
US 20210147265A1 · Andrews et al. · 2021 [cited by applicant]
US 20210179456A1 · Borras et al. · 2021 [cited by applicant]
US 20210188666A1 · Borras et al. · 2021 [cited by applicant]
US 20210188669A1 · Luke et al. · 2021 [cited by applicant]
US 20210221717A1 · Buschmann · 2021 [cited by applicant]
US 20220073380A1 · Schneider et al. · 2022 [cited by applicant]
US 20220073383A1 · Borras et al. · 2022 [cited by applicant]
US 20220081330A1 · Borras et al. · 2022 [cited by applicant]
US 20220106208A1 · Borras et al. · 2022 [cited by applicant]
US 20220305458A1 · Leibfarth et al. · 2022 [cited by applicant]
US 20220315457A1 · Borras et al. · 2022 [cited by applicant]
US 20230264170A1 · Blackburn et al. · 2023 [cited by applicant]
US 20240010528A1 · Borras et al. · 2024 [cited by applicant]
US 20240336500A1 · Borras et al. · 2024 [cited by applicant]
AU 2020291450B2 · 2023 [cited by applicant]
CA 2953591A1 · 2018 [cited by applicant]
CA 3140014A1 · 2020 [cited by applicant]
CA 3140149A1 · 2020 [cited by applicant]
CN 2099752U · 1992 [cited by applicant]
CN 104291415A · 2015 [cited by applicant]
CN 205692940U · 2016 [cited by applicant]
CN 107010699 · 2017 [cited by applicant]
CN 107235537A · 2017 [cited by applicant]
CN 207330680U · 2018 [cited by applicant]
CN 109607691 · 2019 [cited by applicant]
CN 209636053U · 2019 [cited by applicant]
CN 114502512A · 2022 [cited by applicant]
CN 114555214A · 2022 [cited by applicant]
CN 117203166A · 2023 [cited by applicant]
JP S4988166U · 1974 [cited by applicant]
JP S505669B1 · 1975 [cited by applicant]
JP S5140380A · 1976 [cited by applicant]
JP H10473A · 1998 [cited by applicant]
JP H11277066A · 1999 [cited by applicant]
JP 3072838U · 2000 [cited by applicant]
JP 2001276849A · 2001 [cited by applicant]
JP 2003225672A · 2003 [cited by applicant]
JP 2004016868A · 2004 [cited by applicant]
JP 2004066223A · 2004 [cited by applicant]
JP 2005325437A · 2005 [cited by applicant]
JP 2012011375A · 2012 [cited by applicant]
JP 2022537699A · 2022 [cited by applicant]
JP 2022538780A · 2022 [cited by applicant]
JP 7237209B2 · 2023 [cited by applicant]
JP 2024509544 · 2024 [cited by applicant]
JP 7463409 · 2024 [cited by applicant]
PL 224187B1 · 2016 [cited by applicant]
RU 2029735C1 · 1995 [cited by applicant]
RU 2142918C1 · 1999 [cited by applicant]
WO WO2000000670A1 · 2000 [cited by applicant]
WO WO2004046042A2 · 2004 [cited by applicant]
WO WO2008064460A1 · 2008 [cited by applicant]
WO WO2011107984A2 · 2011 [cited by applicant]
WO WO2012048425A1 · 2012 [cited by applicant]
WO WO2013016821A1 · 2013 [cited by applicant]
WO WO2013017901A1 · 2013 [cited by applicant]
WO WO2013075240A1 · 2013 [cited by applicant]
WO WO2014165998A1 · 2014 [cited by applicant]
WO WO2016024408A1 · 2016 [cited by applicant]
WO WO2016054749A1 · 2016 [cited by applicant]
WO 2020247029 · 2020 [cited by applicant]
WO WO2020252241A1 · 2020 [cited by applicant]
WO WO2020252242A1 · 2020 [cited by applicant]
WO WO2021025991A1 · 2021 [cited by applicant]
WO WO2022186877A2 · 2022 [cited by applicant]
WO WO2022186877A3 · 2022 [cited by applicant]
WO WO2023114025A1 · 2023 [cited by applicant]
WO 2023154555 · 2023 [cited by applicant]
WO WO2023205352A1 · 2023 [cited by applicant]
WO 2023215271 · 2023 [cited by applicant]
WO WO2023244720A1 · 2023 [cited by applicant]
WO 2024211729 · 2024 [cited by applicant]
WO 2024211748 · 2024 [cited by applicant]
“U.S. Appl. No. 17/249,343, Corrected Notice of Allowability mailed Dec. 22, 2021”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Final Office Action mailed Oct. 1, 2021”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Non Final Office Action mailed Jun. 15, 2021”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Notice of Allowance mailed Nov. 23, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Response filed Jun. 7, 2021 to Restriction Requirement mailed Apr. 30, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Response filed Sep. 7, 2021 to Non Final Office Action mailed Jun. 15, 2021”, 21 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Response filed Nov. 4, 2021 to Final Office Action mailed Oct. 1, 2021”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,343, Restriction Requirement mailed Apr. 30, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Corrected Notice of Allowability mailed Dec. 10, 2021”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Non Final Office Action mailed Jun. 24, 2021”, 26 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Notice of Allowance mailed Sep. 27, 2021”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Response filed Jun. 7, 2021 to Restriction Requirement mailed May 3, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Response filed Sep. 7, 2021 to Non Final Office Action mailed Jun. 24, 2021”, 19 pgs. [cited by applicant]
“U.S. Appl. No. 17/249,345, Restriction Requirement mailed May 3, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Advisory Action mailed Jan. 24, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Final Office Action mailed Nov. 19, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Non Final Office Action mailed Sep. 23, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Notice of Allowability mailed Apr. 25, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Notice of Allowance mailed Mar. 31, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Response filed Jan. 5, 2022 to Final Office Action mailed Nov. 19, 2021”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Response filed Feb. 21, 2022 to Advisory Action mailed Jan. 24, 2022”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 17/340,254, Response filed Nov. 4, 2021 to Non Final Office Action mailed Sep. 23, 2021”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Non Final Office Action mailed Jan. 10, 2024”, 32 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Response filed Mar. 22, 2024 to Non Final Office Action mailed Jan. 10, 2024”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Advisory Action mailed Mar. 8, 2024”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Final Office Action mailed Dec. 26, 2023”, 30 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Non Final Office Action mailed Jan. 26, 2023”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Non Final Office Action mailed Jun. 28, 2023”, 28 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Response filed Feb. 23, 2024 to Final Office Action mailed Dec. 26, 2023”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Response filed Mar. 23, 2023 to Non Final Office Action mailed Jan. 26, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Response filed Sep. 22, 2023 to Non Final Office Action mailed Jun. 28, 2023”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Final Office Action mailed Oct. 31, 2023”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Non Final Office Action mailed Aug. 7, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Response filed Jan. 24, 2024 to Final Office Action mailed Oct. 31, 2023”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Response filed Sep. 22, 2023 to Non Final Office Action mailed Aug. 7, 2023”, 13 pgs. [cited by applicant]
“Australian Application Serial No. 2020291450, First Examination Report mailed Oct. 28, 2022”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2020291450, Response filed Dec. 19, 2022 to First Examination Report mailed Oct. 28, 2022”, 18 pgs. [cited by applicant]
“Australian Application Serial No. 2020291534, First Examination Report mailed Nov. 9, 2022”, 4 pgs. [cited by applicant]
“Australian Application Serial No. 2020291534, Response filed Mar. 23, 2023 to First Examination Report mailed Nov. 9, 2022”, 10 pgs. [cited by applicant]
“Australian Application Serial No. 2021430769, First Examination Report mailed Mar. 22, 2024”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Examiners Rule 86(2) Report mailed Feb. 9, 2024”, 4 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Examiners Rule 86(2) Report mailed Jul. 17, 2023”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Examiners Rule 86-2 Report mailed Sep. 20, 2022”, 5 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Response filed Jan. 9, 2023 to Examiners Rule 86-2 Report mailed Sep. 20, 2022”, 13 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Response filed Oct. 25, 2023 to Examiners Rule 86(2) Report mailed Jul. 17, 2023”, 25 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Examiners Rule 86(2) Report mailed Mar. 13, 2024”, 7 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Examiners Rule 86(2) Requisition mailed Feb. 27, 2023”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Office Action mailed Aug. 29, 2022”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Response filed Jun. 8, 2023 to Examiners Rule 86(2) Requisition mailed Feb. 27, 2023”, 33 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Response filed Dec. 15, 2022 to Office Action mailed Aug. 29, 2022”, 34 pgs. [cited by applicant]
“Canadian Application Serial No. 3208736, Voluntary Amendment filed Mar. 18, 2024”, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053739.2, Office Action mailed Nov. 29, 2023”, w/ English Translation, 27 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Office Action mailed Feb. 27, 2024”, w/ English translation, 29 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Office Action mailed Mar. 9, 2023”, W/English Translation, 31 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Office Action mailed Sep. 14, 2023”, w/ English Translation, 26 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Response filed Aug. 3, 2023 to Office Action mailed Mar. 9, 2023”, w/ English claims, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Response filed Dec. 26, 2023 to Office Action mailed Sep. 14, 2023”, w/ English claims, 13 pgs. [cited by applicant]
“Enpurion EC-Electrocoagulation”, enpurion https://enpurion.com/empurion-ec/, (Accessed on Feb. 9, 2021), 4 pgs. [cited by applicant]
“European Application Serial No. 20821949.3, Extended European Search Report mailed May 24, 2023”, 11 pgs. [cited by applicant]
“European Application Serial No. 20821949.3, Response filed Dec. 5, 2023 to Extended European Search Report mailed May 24, 2023”, 18 pgs. [cited by applicant]
“European Application Serial No. 20822476.6, Extended European Search Report mailed May 24, 2023”, 10 pgs. [cited by applicant]
“European Application Serial No. 20822476.6, Response filed Dec. 5, 2023 to Extended European Search Report mailed May 24, 2023”, 18 pgs. [cited by applicant]
“European Application Serial No. 20822476.6, Response to Communication pursuant to Rules 161(2) and 162 EPC filed Sep. 1, 2022”, 24 pgs. [cited by applicant]
“European Application Serial No. 20821949.3, Response filed Mar. 31, 2022 to Communication Pursuant to Rules 161(1) & 162 EPC mailed”, 11 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037405, International Preliminary Report on Patentability mailed Dec. 23, 2021”, 11 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037405, International Search Report mailed Sep. 14, 2020”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037405, Written Opinion mailed Sep. 14, 2020”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037407, International Preliminary Report on Patentability mailed Dec. 23, 2021”, 10 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037407, International Search Report mailed Sep. 16, 2020”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/037407, Written Opinion mailed Sep. 16, 2020”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/064124, International Preliminary Report on Patentability mailed Sep. 14, 2023”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/064124, International Search Report mailed Aug. 17, 2022”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/064124, Written Opinion mailed Aug. 17, 2022”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/051651, International Search Report mailed Mar. 28, 2023”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/051651, Written Opinion mailed Mar. 28, 2023”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2023/019295, International Search Report mailed Jul. 21, 2023”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2023/019295, Written Opinion mailed Jul. 21, 2023”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2023/025390, International Search Report mailed Sep. 20, 2023”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2023/025390, Written Opinion mailed Sep. 20, 2023”, 6 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Final Notification of Reasons for Refusal mailed Apr. 4, 2023”, w/ English Translation, 10 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Final Notification of Reasons for Refusal mailed Sep. 5, 2023”, w/ English Translation, 14 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Notification of Reasons for Refusal mailed Dec. 20, 2022”, w/ English Translation, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Response filed Mar. 15, 2023 to Notification of Reasons for Refusal mailed Dec. 20, 2022”, w/ English claims, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Response filed Jul. 3, 2023 to Final Notification of Reasons for Refusal mailed Apr. 4, 2023”, w/ English claims, 10 pgs. [cited by applicant]
“Japanese Application Serial No. 2021-573824, Response filed Dec. 1, 2023 to Final Notification of Reasons for Refusal mailed Sep. 5, 2023”, W/English Claims, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2021573769, Notification of Reasons for Refusal filed Oct. 4, 2022”, w/ English Translation, 6 pgs. [cited by applicant]
“Japanese Application Serial No. 2021573769, Response filed Dec. 22, 2022 to Notification of Reasons for Refusal filed Oct. 4, 2022”, w/ English claims, 14 pgs. [cited by applicant]
“Ship Corrosion Protection Technology”, Ha'erbin: Harbin Engineering University Press Abstract with English Translation, (Feb. 28, 2011), 10 pgs. [cited by applicant]
“Treatment Technologies for Per- and Polyfluoroalkyl Substances (PFAS)”, Fact Sheet, (Sep. 2023), 4 pgs. [cited by applicant]
Al-Qodah, Zakaria, et al., “Combined electrocoagulation processes as a novel approach for enhanced pollutants removal: A state-of-the-art review”, Science of the Total Environment 744, (2020), 14 pgs. [cited by applicant]
Bensadok, K, et al., “Electrocoagulation of cutting oil emulsions using aluminium plate electrodes”, Journal of Hazardous Materials 152, (2008), 423-430. [cited by applicant]
Deng, Shubo, et al., “Removal of perflurooctanoate from surface water by polyaluminium choloride coagulation”, Water Research vol. 45 Issue 4 1774-1780, (Feb. 2011), 5 pgs. [cited by applicant]
Dina, T Moussa, et al., “A comprehensive review of electrocoagulation for water treatment: Potentials and challenges”, Journal of Environmental Management 186, (2017), 24-41. [cited by applicant]
Garg, Shafali, et al., “Remediation of water from per-/poly-fluoroalkyl substances (PFAS)-Challenges and perspectives”, Journal of Environmental Chemical Engineering 9, (2021), 25 pgs. [cited by applicant]
Gobbi, Lorena C.A., et al., “Electrocoagulation with polarity switch for fast oil removal from oil in water emulsions”, Journal of Environmental Management 213, (2018), 119-125. [cited by applicant]
Govindan, Kadarkarai, et al., “Electrocoagulants Characteristics and Application of Electrocoagulation for Micropollutant Removal and Transformation Mechanism”, ACS Appl Mater. Interfaces 12, (2020), 1775-1788. [cited by applicant]
Hubert, Michel, et al., “Per- and polyfluoroalkyl substance (PFAS) removal from soil washing water by coagulation and flocculation”, Water Research 249, (2023), 10 pgs. [cited by applicant]
Jizhou, L, et al., “Pretreatment of dyestuff wastewater by internal microelectrolysis”, International Conference on Electric Technology and Civil Engineering, (2011), 4 pgs. [cited by applicant]
Kabdasli, I, et al., “Electrocoagulation applications for industrial wastewaters: a critical review”, Environmental Technology Reviews, (Nov. 6, 2012), 45 pgs. [cited by applicant]
Kekedy-Nagy, Laszlo, et al., “Electroless Production of Fertilizer (Struvite) and Hydrogen from Synthetic Agricultural Wastewaters”, Journal of the American Chemical Society J. Am. Chem. Soc 142, (2020), 15 pgs. [cited by applicant]
Kuokkanen, Ville, et al., “Recent Applictions of Electrocoagulation in Treatment of Water and Wastewater—A Review”, Green and Sustainable Chemistry, (Jan. 2013), 34 pgs. [cited by applicant]
Lu, Xinyu, et al., “Adsorption behavior and mechanism of perfluorooctane sulfonate on nanosized inorganic oxides”, Journal of Colloid and Interface Science vol. 474 pp. 199-205, (Jul. 15, 2016), 6 pgs. [cited by applicant]
Luba, Mateusz, et al., “Electrochemical Degradation of Industrial Dyes in Wastewater through the Dissolution of Aluminum Sacrificial Anode of Cu/Al Macro-Corrosion Galvanic Cell”, Molecules (18) 4108, (Sep. 25, 2020), 1… [cited by applicant]
Malik, Qasim H, “Performance of alum and assorted coagulants in turbidity removal of muddy water”, Applied Water Science, (2018), 4 pgs. [cited by applicant]
Merino, Nancy, et al., “Degradation and Removal Methods for Perfluoroalky and Polyfluoroalkyl Substances in Water”, Environmental Engineering Science vol. 33, No. 9, (Sep. 1, 2016), 60 pgs. [cited by applicant]
Peng, Shuai, et al., “Iron-carbon galvanic cells strengthened anaerobic/anoxic/oxicprocess(Fe/C-A2O) for high-nitrogen/phosphorus and low-carbon sewage treatment”, Science of the Total Environment 722, (2020), 13 pgs. [cited by applicant]
Pierozynski, Boguslaw, “Electrochemical Degradation of Phenol and Resorcinol Molecules through the Dissolution of Sacrificial Anodes of Macro-Corrosion Galvanic Cells”, Water 10:770, (2018), 10 pgs. [cited by applicant]
Wei, V, et al., “Nutrient removal in an electrically enhanced membrane Bioreactor”, Water Science & Technology, vol. 60, No. 12, (Dec. 1, 2009), 3159-3163. [cited by applicant]
Xiao, Feng, et al., “Mechanisms for removal of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) from drinking water by conventional enhances coagulation”, Water Research vol. 47, Issue 1 pp. 49-56, (Jan. 1… [cited by applicant]
Zhang, D Q, et al., “Adsorption of perfluoroalkyl and polyfluoroalkyl substances (PFASs) from aqueous solution—A review”, Science of the Total Environment 694, (2019), 19 pgs. [cited by applicant]
Zhang, Mingkun, et al., “Aluminum-based electrocoagulation for residual fluoride removal during per-and polyfluoroalkyl substances (PFASs) wastewater treatment”, Separation and Purification Technology vol. 308, (Mar. 20… [cited by applicant]
Zhang, Zhiming, et al., “Adsorption of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) by aluminum-based drinking water treatment residuals”, Journal of Hazardous Materials Letters, (2021), 6 pgs. [cited by applicant]
“European Application Serial No. 21929411.3, Response to Communication pursuant to Rules 161(2) and 162 EPC filed Apr. 5, 2024”, 19 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Response filed Apr. 23, 2024 to Advisory Action mailed Mar. 8, 2024”, 21 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Non Final Office Action mailed Apr. 24, 2024”, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202180097592.1, Office Action mailed Apr. 2, 2024”, W English Translation, 22 pgs. [cited by applicant]
“Canadian Application Serial No. 3,208,736, Examiners Rule 86(2) Requisition mailed May 6, 2024”, 5 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Response filed May 27, 2024 to Examiners Rule 86(2) Report mailed Feb. 9, 2024”, 25 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Response filed Jun. 5, 2024 to Final Office Action mailed Apr. 24, 2024”, 7 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Response filed Jun. 7, 2024 to Examiners Rule 86(2) Report mailed Mar. 13, 2024”, 38 pgs. [cited by applicant]
“International Application Serial No. PCT US2024 023323, Invitation to Pay Additional Fees mailed Jun. 14, 2024”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 18 628,020, Notice of Allowance mailed Jun. 20, 2024”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Corrected Notice of Allowability mailed Oct. 1, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Final Office Action mailed Jul. 15, 2024”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Notice of Allowance mailed Sep. 24, 2024”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Response filed Sep. 16, 2024 to Final Office Action mailed Jul. 15, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Non Final Office Action mailed Jul. 10, 2024”, 28 pgs. [cited by applicant]
“U.S. Appl. No. 17/554,229, Non Final Office Action mailed Sep. 18, 2024”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Notice of Allowability mailed Aug. 30, 2024”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/838,361, Notice of Allowance mailed Aug. 16, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/371,603, Non Final Office Action mailed Aug. 27, 2024”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 18/628,020, Supplemental Notice of Allowability mailed Jul. 5, 2024”, 2 pgs. [cited by applicant]
“Canadian Application Serial No. 3,208,736, Response filed Aug. 12, 2024 to Examiners Rule 86(2) Requisition mailed May 6, 2024”, 17 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053739.2, Office Action mailed Jun. 13, 24”, W/English Translation, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053739.2, Response filed Aug. 13, 2024 to Office Action mailed Jun. 13, 2024”, w/English claims, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Office Action mailed May 29, 2024”, W/English Translation, 23 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Response filed Apr. 29, 2024 to Office Action mailed Feb. 27, 2024”, w/ English claims, 21 pgs. [cited by applicant]
“Chinese Application Serial No. 202180097592.1, Office Action mailed Sep. 10, 2024”, w/ English Translation, 13 pgs. [cited by applicant]
“Chinese Application Serial No. 202180097592.1, Response filed Aug. 1, 2024 to Office Action mailed Apr. 2, 2024”, w/ current English claims, 8 pgs. [cited by applicant]
“European Application Serial No. 21929411.3, Communication pursuant to Rule 164(1) EPC mailed Sep. 11, 2024”, 18 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/051651, International Preliminary Report on Patentability mailed Jun. 27, 2024”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2024/023295, International Search Report mailed Jul. 17, 2024”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2024/023295, Written Opinion mailed Jul. 17, 2024”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2024/023323, International Search Report mailed Aug. 27, 2024”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2024/023323, Written Opinion mailed Aug. 27, 2024”, 7 pgs. [cited by applicant]
“Japanese Application Serial No. 2023-553408, Notification of Reasons for Rejection mailed Jul. 23, 2024”, W/English Translation, 10 pgs. [cited by applicant]
Wang, Fei, “Adsorption behavior of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) on boehmit”, Chemosphere 89 1009-1014, (2012), 6 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,014, Office Action mailed Oct. 1, 2024”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/533,522, Response filed Oct. 4, 2024 to Non Final Office Action mailed Jul. 10, 2024”, 21 pgs. [cited by applicant]
“U.S. Appl. No. 17/530,907, Supplemental Notice of Allowability mailed Oct. 9, 2024”, 3 pgs. [cited by applicant]
“Japanese Application Serial No. 2023-553408, Response filed Oct. 23, 2024 to Notification of Reasons for Rejection mailed Jul. 23, 2024”, W English Claims, 11 pgs. [cited by applicant]
“European Application Serial No. 20821949.3, Communication Pursuant to Article 94(3) EPC mailed Oct. 25, 2024”, 8 pgs. [cited by applicant]
“Australian Application Serial No. 2021430769, Response filed Oct. 28, 2024 to First Examination Report mailed Mar. 22, 2024”, 136 pgs. [cited by applicant]
“International Application Serial No. PCT US2023 019295, International Preliminary Report on Patentability mailed Oct. 31, 2024”, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202180097592.1, Response filed Oct. 31, 2024 to Office Action mailed Sep. 10, 2024”, w current English claims, 14 pgs. [cited by applicant]
“U.S. Appl. No. 18/371,603, Response filed Nov. 7, 2024 to Non Final Office Action mailed Aug. 27, 2024”, 14 pgs. [cited by applicant]
“Australian Application Serial No. 2021430769, Subsequent Examination Report mailed Nov. 4, 2024”, 3 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Decision of Rejection mailed Oct. 25, 2024”, w English translation, 29 pgs. [cited by applicant]
“Chinese Application Serial No. 202080053751.3, Response filed Sep. 29, 2024 to Office Action mailed May 29, 2024”, w English claims, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/554,229, Response filed Dec. 16, 2024 to Non Final Office Action mailed Sep. 18, 2024”, 13 pgs. [cited by applicant]
“Canadian Application Serial No. 3,140,149, Office Action mailed Dec. 2, 2024”, 4 pgs. [cited by applicant]
“European Application Serial No. 21929411.3, Extended European Search Report mailed Dec. 3, 2024”, 19 pgs. [cited by applicant]
“Chinese Application Serial No. 202180097592.1, Decision of Rejection mailed Nov. 26, 2024”, w English Translation, 14 pgs. [cited by applicant]
Cited By (1)
US 12,492,137